期刊文献+

内皮素-1对紫杉醇诱导激素非依赖性前列腺癌细胞PC3凋亡的影响 被引量:3

Influence of endothelin-1 on apoptosis induced by paclitaxel in hormone refractory prostate cancer cell line PC3
下载PDF
导出
摘要 目的观察内皮素-1(endothelin-1,ET-1)对紫杉醇诱导激素非依赖性前列腺癌细胞PC3凋亡的影响,并研究其机制。方法采用人激素非依赖性前列腺癌细胞株PC3,设对照组、紫杉醇组、紫杉醇+ET-1组。流式细胞仪测定PC3细胞周期分布和凋亡细胞百分比。免疫沉淀(immunoprecipitation,IP)及Western blot检测PC3细胞Bcl-2、Bax和Bax/Bcl-2异二聚体的表达。结果紫杉醇+ET-1组PC3细胞的G0-G1(%)高于紫杉醇组,G2-M(%)低于紫杉醇组,凋亡细胞百分比低于紫杉醇组,差异有统计学意义(P<0.05)。紫杉醇+ET-1组PC3细胞的Bcl-2磷酸化水平显著低于紫杉醇组,Bax/Bcl-2异二聚体水平显著高于紫杉醇组,差异有统计学意义(P<0.05)。结论ET-1能逆转紫杉醇对PC3细胞的G2/M期阻滞,并能通过影响Bcl-2磷酸化作用于细胞凋亡通路,减少细胞凋亡,从而降低激素非依赖性前列腺癌PC3细胞对紫杉醇的敏感性。 Objective To investigate influence of endothelin-1 (ET-1) on apoptosis induced by paclitaxel in hormone refractory prostate cancer line PC3, and further investigate its mechanism. Methods Hormone refractory prostate cancer cell PC3 was cultured in vitro and divided into control group, Paclitaxel group and Paelitaxel + ET-1 group. Distribution of cell cycles and percentage of apoptotic cells was detected by flow cytometry, and the level of Bcl-2, Bax and Bax/Bcl-2 heterodimer was determined by immunopreeipitation and Western blot. Results Compared with paclitaxel group, PC3 cells in paclitaxel + ET-1 group showed a increased G0-G1 percentage and decreased G2-M percentage in cell cycle and a decreased percentage of apoptotie cells, and showed a decreased phosphorylation level of Bcl-2 and increased Bax/Bcl-2 heterodimer level. All results had significant difference(P〈0.05). Conclusions ET-1 could reverse paelitaxel-induced G2/M phase blockade and protect PC3 cells from paclitaxel-induced apoptosis by decreasing Bcl-2 phosphorylation to influence apoptotic pathways, thereby reduced hormone refractory prostate cancer ceil PC3's sensibility to paclitaxel.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2008年第5期756-759,共4页 Fudan University Journal of Medical Sciences
关键词 内皮素-1 激素非依赖性前列腺癌 紫杉醇 凋亡 endothelin-1 hormone refractory prostate cancer paclitaxel apoptosis
  • 相关文献

参考文献9

  • 1Prapotnich D.Fizazi K. Escudier B. et al. A 10 year clinical experience with intermittent hormonal therapy for prostate cancer[J]. Eur Urol, 2003,43 (3) : 233 - 2411.
  • 2Ndson JB, Hedican SP, George DJ, et al. ldentification of endothelin-1 in the pat hophysiology of metastatic adenocarcinoma of the prostate[J]. Nat Med, 1995,1 (9) : 944 949
  • 3Zonnenberg BA,Voest EE. The role of endothelin in hormone- refractory prostate cancer[J]. Eur Urol,2003,2(3) :9- 14.
  • 4武睿毅,王杭,王国民.内皮素-1对前列腺癌PC3细胞系的侵袭、迁移能力影响[J].复旦学报(医学版),2005,32(5):590-593. 被引量:2
  • 5Nelson JB, Chan-Tack K, Hedican SP, et al. Endothelin-1 production and decreased endothelin-B receptor expression in advanced prostate cancer[J]. Cancer Res, 1996, 56(4): 663 - 668.
  • 6Del Bufalo D, Di Castro V, Biroccio A, et al. Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for akt activation[J]. Mol Pharmacol, 2002,61(3) :524- 532.
  • 7Nelson J,Bagnato A, Battistini B, et al. The endothelin axis: emerging role in cancer[J]. Nat Rev Cancer,2003,3(2) : 110-116.
  • 8Haldar S, Chinlapalli J. Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells[J]. Cancer Res ,1996,56(6):1 253 - 1 255.
  • 9Pienta KJ, Smith DC. Advances in prostate chemotherapy: a new era begins[J]. CA Cancer J Clin,2005, 55(5):300-318.

二级参考文献11

  • 1Crawford ED, Rosenblum M, Ziada AM, et al. Overview: hormone refractory prostate cancer. Urology, 1999,54 (6A Suppl): 1.
  • 2Cheville JC,Tindall D,Boelter C, et al. Metastatic prostate carcinoma to bone:clinical and pathologic features associated with cancerspecific survival. Cancer ,2002,95:1028.
  • 3Nelson JB,Hedican SP,George DJ, et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med, 1995,1 (9): 944.
  • 4Nelson J,Bagnato A,Battistini B, et al. The endothelin axis: emerging role in cancer. Nat Rev Cancer ,2003,3(2) :110.
  • 5Salani D, Garagoletti G, Rosano L, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo . Amer J Path ,2000,157:1703.
  • 6Nelson JB, Chan-Tack K, Hedican SP, et al. Endothelin-1 production and decreased endothelin-B receptor expression in advanced prostate cancer. Cancer Res, 1996,56:663.
  • 7Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res,1987,47: 3239.
  • 8Festuccia C, Bologna M, Gravina GL, et al. Osteoblast conditioned media contain TGF-β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer, 1999,81:395.
  • 9Burkhardt M,Barton M,Shaw SG. Receptor- and non-receptor-mediated clearance of big-endothelin andendothelin-1: differential effects of acute and chronic ETA receptor blockade. J Hypertens,2000,18:273.
  • 10McCawley LJ,Matrisian LM. Matrix metalloproteinases:multifunctional contributors to tumor progression. Mol Med Today ,2000,6:149.

共引文献1

同被引文献41

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部